Fact CheckerSign in

NCT05255705Recruiting

Barts Revascularisation Registry

Barts Revascularisation Registry - To Understand the Characteristics, Time-trends and Outcomes in Patients With Coronary Artery Disease at Barts Heart Centre

Source: ClinicalTrials.gov · Last updated 5 Oct 2026

Brief summary (registry, in English)

Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we can now treat CAD using minimally invasive interventional techniques. This has revolutionised treatment for and improved the lives of many patients with CAD. Although trials have assessed various therapeutic strategies in various populations, real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide. This data will add to that literature by assessing the characteristics and outcomes of patients with CAD. It will also identify and characterise predictors of outcomes, improve risk stratification and diagnostic evaluation.

Status (registry)
Recruiting
Study type
Observational
Enrollment
20000 (estimated)
First submitted
18 Jan 2022
Start date
6 Aug 2021
Primary completion date
30 Mar 2030
Lead sponsor
Queen Mary University of London
NCT number
NCT05255705

What you commit to

  • Study type: Observational
  • Planned participants: 20000
  • From 6 Aug 2021 to the primary completion date, 30 Mar 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Patients \<16 years will not be included in this study.

Who the study is looking for

  • Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes.
  • No children will be included in this study.
  • Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team.
  • Both male and female patients ≥16 years of age will be included
  • All patients will have had an angiogram at BHC.
  • Any patient who has undergone revascularisation.

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Barts Health NHS Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.